HOME >> BIOLOGY >> NEWS
Genetic defect confers risk of major depression, resistance to SSRI drug therapy

DURHAM, N.C. A newly discovered genetic defect might represent an important risk factor for major depression, a condition which effects 20 million people in the U.S., according to Duke University Medical Center researchers. The mutation in the gene -- whose protein product plays a primary role in synthesizing the brain chemical serotonin -- could lead to the first diagnostic test for genetic predisposition to depression, the team said.

"Abnormalities in brain levels of serotonin have been widely suspected as a key contributor to major depression and other neuropsychiatric disorders," said James B. Duke professor Marc Caron, Ph.D., a researcher in the department of cell biology, the Duke Institute for Genome Sciences and Policy and senior author of the study. "Our findings provide a novel molecular mechanism underlying dysfunction in serotonin neurotransmission in some patients with depression."

The genetic defect is the first genetic variant of functional consequence in the production of serotonin identified in any psychiatric disorder, the researchers said.

Patients with depression who carry the abnormal gene also show resistance to treatment with selective serotonin reuptake inhibitors (SSRIs), a class of drugs that includes paroxetine (PaxilTM), sertraline (ZoloftTM), and fluoxetine (ProzacTM), the team found. In addition to its diagnostic use, the genetic marker might therefore also aid in identifying, in advance, those patients who will likely fail to respond well to SSRI therapy.

The researchers further suggest that this and other variants of the gene might also explain such paradoxical adverse reactions to SSRI treatment as suicidal behavior and SSRI-exacerbated mania and psychosis.

The Duke team reported its findings Dec. 9, 2004, in the early online edition of Neuron. The work was supported by the National Institutes of Health, the Human Frontiers Science Program and the C
'"/>

Contact: Kendall Morgan
kendall.morgan@duke.edu
919-660-1306
Duke University Medical Center
9-Dec-2004


Page: 1 2 3 4

Related biology news :

1. Genetic variation helps to understand predisposition to schizophrenia
2. Genetic factors strongly shape how peers are chosen
3. Genetic analysis finds greater threat in frog-killing fungus
4. Genetic diversity in honeybee colonies boosts productivity
5. 2007-2008 Genzyme/ACMGF Clinical Genetics Fellowship In Biochemical Genetics award winner announced
6. Maynard Olson receives $500,000 Gruber Genetics Prize
7. Genetic defect links respiratory disease and congenital heart disease
8. Cell Press announces new partnership with the American Society of Human Genetics
9. Genetic fellow traveler discovered in Alzheimers
10. Genetic roots of bipolar disorder revealed by first genome-wide study of illness
11. Health disparities -- Genetics, society and race play an important role in access to healthcare

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... (PRWEB) , ... January 23, ... ... of a new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute ... Institute. ARMI brings together a consortium of over 100 partner organizations from ...
(Date:1/22/2020)... ... January 21, 2020 , ... ... chain operations, developing transport validation strategies, supporting global regulatory applications, and executing ... and the Houston Business Journal as a fastest growing company, and ISO ...
(Date:1/7/2020)... ... January 07, 2020 , ... ... features not just part numbers like what can be found in most catalogs, ... supports, and that is all linked to the impact it has on the ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... , ... January 27, 2020 , ... ... in neuroscience and cloud and mobile computing, today announced the availability of neuroscience ... an organization to use the latest neuroscience of leadership and change research to ...
(Date:1/23/2020)... ... 2020 , ... Ideal Implant CEO and President Robert S ... North American investor forums specializing in medical advancements. New technology was presented to ... on November 21, 2019 in New York City, and the Aesthetic Technology Summit ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... establishes benchmarks for the vendor qualification process, a critical element of clinical ... volume and complexity of the vendor qualification process creates delays in initiation in ...
(Date:1/7/2020)... ... January 07, 2020 , ... Absolute Antibody Ltd. , ... of its VivopureX™ recombinant mouse antibodies for in vivo research in mouse models. ... hamsters, which Absolute Antibody has engineered into mouse-anti-mouse recombinant versions to improve research ...
Breaking Biology Technology:
Cached News: